Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00446966 · ClinicalTrials.gov registry record · Phase 4
Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery
A Phase 4 study of Atrial Fibrillation, sponsored by Chirag Sandesara.
- Completed
- Registry status
- Phase 4
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT00446966: Completed Phase 4 study of Atrial Fibrillation, sponsored by Chirag Sandesara.
NCT00446966 is a Phase 4 study of Atrial Fibrillation that has completed, run by Chirag Sandesara. The registered enrollment target is 260 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00446966, a Phase 4 study of Atrial Fibrillation, has completed, sponsored by Chirag Sandesara.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine if omega-3 polyunsaturated fatty acids reduce atrial fibrillation and other outcomes after cardiac surgery. In this placebo-controlled trial, patients undergoing elective coronary artery bypass graft surgery with or without valve repair will be treated with omega-3 polyunsaturated fatty acids perioperatively. The following hypotheses will be tested: 1. omega-3 polyunsaturated fatty acids reduces the incidence of atrial fibrillation (AF) after cardiac surgery, 2. omega-3 polyunsaturated fatty acids, administered in the perioperative period for cardiac surgery, decreases postoperative complication rates, and 3. omega-3 polyunsaturated fatty acids decrease intensive care unit and hospital length-of-stay.
Primary Outcome
The primary outcome in this study is post-bypass atrial fibrillation documented by ECG or rhythm strip and requiring treatment.
Conditions Studied
Interventions
- DRUG Omega Three Polyunsaturated fatty acids
Study Locations (1)
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2007-02 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
What the finished NCT00446966 record still lists
NCT00446966 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Omega Three Polyunsaturated fatty acids is the first listed.
NCT00446966 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT00446966 about?
NCT00446966 is a clinical study titled "Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery". The primary objective of this study is to determine if omega-3 polyunsaturated fatty acids reduce atrial fibrillation and other outcomes after cardiac surgery. In this placebo-controlled trial, patients undergoing elective coronary artery bypass graft surgery with or without valve repair will be tre...
What is the current status of trial NCT00446966?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 260 participants. The study started on 2007-02. Estimated completion is 2010-01.
What conditions does trial NCT00446966 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT00446966?
The interventions under investigation include: Omega Three Polyunsaturated fatty acids (DRUG).
Who is sponsoring clinical trial NCT00446966?
This trial is sponsored by Chirag Sandesara, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00446966 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00446966's enrollment target sits among peer trials
260 88th of 202 higher than 115 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
RECRUITING · Phase 4
-
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
RECRUITING · Phase 4
-
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
RECRUITING · Phase 4
-
Ondansetron for the Management of Atrial Fibrillation
RECRUITING · Phase 4
-
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
ACTIVE NOT RECRUITING · Phase 4
-
Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia